A comprehensive view of gsk group (glaxosmithkline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GSK Group (GlaxoSmithKline) Champions Immunization and Cancer Prevention as Strategic Health Investments
Published: April 26, 2024 by Industry Intelligence Inc.
GSK Group (GlaxoSmithKline) Leads the Charge Against Malaria with World's First Vaccine and Strategic Global Health Initiatives
Published: April 25, 2024 by Industry Intelligence Inc.
European Patent Office Releases GlaxoSmithKline Biologicals's Patent Application for Release Assay for Determining Potency of Self-Amplifying RNA Drug Product and Methods for Using
Published: April 24, 2024 by Pharmaceutical Patent News
FDA accepts for priority review GSK’s application for an expanded indication of Jemperli dostarlimab-gxly plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer
Published: April 24, 2024 by GSK Group (GlaxoSmithKline)
US Patent Issued to GLAXOSMITHKLINE on April 23 for "Platelet count-agnostic methods of treating myelofibrosis" (Michigan Inventors)
Published: April 24, 2024 by U.S. Fed News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count